Relief of dyspnea with high-flow nasal therapy in palliative care
Official title: Management of Dyspnea With High- Flow Nasal Therapy
Run by Tampere University Hospital · NCT07552935 · Data updated 2026-11-12
This study tests whether high-flow nasal therapy helps relieve breathlessness in adults receiving palliative care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 2 sites (Tampere and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT07552935 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) in palliative care with significant dyspnea (NRS ≥ 4) who are not expected to benefit from ICU-level or invasive ventilation.
✕Probably not a fit
Patients with inability to tolerate HFNT, delirium or inability to consent, or dyspnea caused by conditions immediately treatable by other means may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In adults with incurable illnesses, severe dyspnea can greatly reduce quality of life. This trial examines high-flow nasal therapy (HFNT) delivered via a nasal cannula, with airflow directed toward the face as a potential option for comfort. Participants receive HFNT and face-directed airflow, and feasibility and relief of dyspnea are assessed in palliative care settings. The study targets 30–40 patients recruited from the Hatanpää Palliative Care Ward and Pirkanmaa Hospice in Tampere, Finland. Eligibility requires age 18+, significant dyspnea (NRS ≥ 4), and informed consent.
Why it matters
Potential benefit: If successful, HFNT could become a feasible modality to lessen breathlessness and improve comfort for patients in palliative care.
How similar studies have gone: HFNT has shown signal of dyspnea relief in cancer patients, but its use in hospice/palliative settings is not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient is in palliative care (ICD-10 diagnostic code Z51.5 palliative care) * Age ≥ 18 years * Ability to understand the study and provide informed consent to participate * Significant breathlessness (NRS = Numeric Rating Scale ≥ 4). * The treating physician has assessed that the patient would not benefit from treatment in intensive care unit or monitor unit. * The treating physician has assessed that the patient would not benefit from invasive mechanical ventilation (intubation) or cardiopulmonary resuscitation. Exclusion Criteria: * Decreased level of consciousness, delirium, or other lack of cooperation that prevents participation. * Respiratory support other than HFNT is required. * The patient has received HFNT during the same admission to palliative care ward or hospice. * The cause of dyspnea can be treated immediately. * Inability to provide informed consent to participate.
Where it's running
-
Pirkanmaa Hospice
Tampere, Finland Recruiting -
Hatanpää hospital, Palliative Care Centre and Home Hospital Services, Wellbeing Services County of Pirkanmaa, Tampere University Hospital
Tampere, Finland Recruiting
Study contacts
- Principal investigator: Juho Lehto, Professor — Tampere University Hospital and Tampere University, Tampere, Finland.
- Study coordinator: Juho Lehto, Professor
- Email: juho.lehto@tuni.fi
- Phone: +358 50 4090974
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
-
Physiotherapist check for breathing pattern problems
This project will test whether a physiotherapist checklist called the BPAT can spot breathing pattern disorder and track changes after physiotherapy in people with breathlessness, asthma, or healthy volunteers.
-
Palliative and supportive care to help people with inflammatory arthritis live well
This project will see how palliative and supportive care could help adults with inflammatory arthritis live better throughout their illness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.